Trials / Completed
CompletedNCT05968443
Dafilon® Suture Material in Patients Undergoing Ophthalmic Surgery
Observational, Retrospective Clinical Study in Patients Undergoing Ophthalmic Surgery Using Dafilon® Suture Material (Dafilon® USP (United States Pharmacopeia) Sizes From 8/0 to 11/0)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This is an observational, retrospective postmarket clinical follow-up study and includes all patients who underwent any ophthalmic surgery using Dafilon® suture in the selected centres between 2018 and 2020, therefore no sample size can be given but the planned sample size shall be at least 200 eyes (around 100 patients depending on the number of operated eyes per patient) to conduct meaningful subgroup analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ophthalmic surgery | any ophthalmic surgery using Dafilon® suture |
Timeline
- Start date
- 2019-01-08
- Primary completion
- 2021-07-01
- Completion
- 2022-05-10
- First posted
- 2023-08-01
- Last updated
- 2023-08-01
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT05968443. Inclusion in this directory is not an endorsement.